berberine has been researched along with thyroxine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Dai, DZ; Jiang, JM | 1 |
Xu, JG; Yang, J; Zhou, ZY | 1 |
Dai, DZ; Dai, Y; Huang, ZJ; Na, T; Zhang, Y | 1 |
Dai, DZ; Dai, Y; Du, RH; Tang, WH; Yi, HW | 1 |
5 other study(ies) available for berberine and thyroxine
Article | Year |
---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
p-Chlorobenzyltetrahydroberberine inhibits vascular smooth muscle contractions caused by Ca2+.
Topics: Animals; Aorta, Thoracic; Bepridil; Berberine; Biological Transport, Active; Calcium; Calcium Channel Blockers; Female; Hyperthyroidism; Male; Mice; Mice, Inbred ICR; Muscle Contraction; Muscle, Smooth, Vascular; Nimodipine; Rats; Rats, Sprague-Dawley; Thyroxine; Verapamil | 1998 |
[Protective effect of berberine on cardiac hypertrophy induced by L-thyroxine in rats].
Topics: Animals; Berberine; Calcium-Transporting ATPases; Cardiomegaly; Female; Male; Protein Subunits; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Thyroxine | 2004 |
Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017.
Topics: Animals; Anti-Arrhythmia Agents; Aspartic Acid Endopeptidases; Berberine; Calcium; Cardiomyopathies; Cyclic AMP-Dependent Protein Kinases; Endothelin-Converting Enzymes; Heart; Humans; Metalloendopeptidases; Molecular Structure; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Rats; Reperfusion; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tacrolimus Binding Proteins; Thyroxine; Ventricular Fibrillation | 2007 |
Inflammatory factors that contribute to upregulation of ERG and cardiac arrhythmias are suppressed by CPU86017, a class III antiarrhythmic agent.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Aspartic Acid Endopeptidases; Berberine; Cardiomegaly; Cardiomyopathies; Disease Models, Animal; Endothelin-1; Endothelin-Converting Enzymes; Ether-A-Go-Go Potassium Channels; Inflammation Mediators; Male; Metalloendopeptidases; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Propranolol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thyroxine; Transforming Growth Factor beta; Up-Regulation; Ventricular Fibrillation | 2008 |